106 related articles for article (PubMed ID: 26053181)
21. TGF-β2-induced ANGPTL4 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone.
Li B; Qian M; Cao H; Jia Q; Wu Z; Yang X; Ma T; Wei H; Chen T; Xiao J
Oncotarget; 2017 Aug; 8(33):54966-54977. PubMed ID: 28903395
[TBL] [Abstract][Full Text] [Related]
22. Small non-coding RNAs-based bone regulation and targeting therapeutic strategies.
Yang Y; Fang S
Mol Cell Endocrinol; 2017 Nov; 456():16-35. PubMed ID: 27888003
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and prognoses of six patients with multicentric giant cell tumor of the bone.
Liu C; Tang Y; Li M; Jiao Q; Zhang H; Yang Q; Yao W
Oncotarget; 2016 Dec; 7(50):83795-83805. PubMed ID: 27823978
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of filamin B splice variants in giant cell tumor cells.
Tsui JC; Lau CP; Cheung AC; Wong KC; Huang L; Tsui SK; Kumta SM
Oncol Rep; 2016 Dec; 36(6):3181-3187. PubMed ID: 27779699
[TBL] [Abstract][Full Text] [Related]
25. RANK pathway in giant cell tumor of bone: pathogenesis and therapeutic aspects.
Wu PF; Tang JY; Li KH
Tumour Biol; 2015 Feb; 36(2):495-501. PubMed ID: 25618600
[TBL] [Abstract][Full Text] [Related]
26. Pathologic conditions of hard tissue: role of osteoclasts in osteolytic lesion.
Kitazawa R; Haraguchi R; Fukushima M; Kitazawa S
Histochem Cell Biol; 2018 Apr; 149(4):405-415. PubMed ID: 29356963
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone.
Wang T; Yin H; Wang J; Li Z; Wei H; Liu Z; Wu Z; Yan W; Liu T; Song D; Yang X; Huang Q; Zhou W; Xiao J
Oncotarget; 2015 Aug; 6(22):18980-96. PubMed ID: 26053181
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-16-5p Inhibits Osteoclastogenesis in Giant Cell Tumor of Bone.
Sang S; Zhang Z; Qin S; Li C; Dong Y
Biomed Res Int; 2017; 2017():3173547. PubMed ID: 28589137
[TBL] [Abstract][Full Text] [Related]
29. MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13.
Wu Z; Yin H; Liu T; Yan W; Li Z; Chen J; Chen H; Wang T; Jiang Z; Zhou W; Xiao J
Biochem Biophys Res Commun; 2014 Jan; 443(3):944-9. PubMed ID: 24360951
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR-223 and miR-19a induces differentiation and promotes recruitment of osteoclast cells in giant-cell tumor of the bone via the Runx2/TWIST-RANK/RANKL pathway.
Jiang ZY; Jiang JJ; Ma YS; Li HY; Shi W; Fu PL; Xu CF; Lu JZ; Fu D; Xu JG
Biochem Biophys Res Commun; 2018 Nov; 505(4):1003-1009. PubMed ID: 30309658
[TBL] [Abstract][Full Text] [Related]
31. MiR-30a inhibits osteolysis by targeting RunX2 in giant cell tumor of bone.
Huang Q; Jiang Z; Meng T; Yin H; Wang J; Wan W; Cheng M; Yan W; Liu T; Song D; Chen H; Wu Z; Xu W; Li Z; Zhou W; Xiao J
Biochem Biophys Res Commun; 2014 Oct; 453(1):160-5. PubMed ID: 25264196
[TBL] [Abstract][Full Text] [Related]
32. MiR-377 inhibits wear particle-induced osteolysis via targeting RANKL.
Li W; Wang X; Chang L; Wang F
Cell Biol Int; 2019 Jun; 43(6):658-668. PubMed ID: 30958621
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation.
Li CJ; Cheng P; Liang MK; Chen YS; Lu Q; Wang JY; Xia ZY; Zhou HD; Cao X; Xie H; Liao EY; Luo XH
J Clin Invest; 2015 Apr; 125(4):1509-22. PubMed ID: 25751060
[TBL] [Abstract][Full Text] [Related]
34. Treatment and outcome of primary aggressive giant cell tumor in the spine.
Yin H; Yang X; Xu W; Li B; Li B; Wang T; Meng T; Wang P; Liu T; Zhou W; Xiao J
Eur Spine J; 2015 Aug; 24(8):1747-53. PubMed ID: 25631339
[TBL] [Abstract][Full Text] [Related]
35. Subchondral bone influences chondrogenic differentiation and collagen production of human bone marrow-derived mesenchymal stem cells and articular chondrocytes.
Leyh M; Seitz A; Dürselen L; Schaumburger J; Ignatius A; Grifka J; Grässel S
Arthritis Res Ther; 2014 Oct; 16(5):453. PubMed ID: 25296561
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
